spacer
spacer

PDBsum entry 7kec

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Viral protein PDB id
7kec

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
966 a.a.
Ligands
NAG-NAG ×12
NAG ×33
PDB id:
7kec
Name: Viral protein
Title: Sars-cov-2 d614g 1-rbd-up spike protein trimer without the p986-p987 stabilizing mutations (s-gsas-d614g sub-classification)
Structure: Spike glycoprotein. Chain: a, b, c. Synonym: s glycoprotein,e2,peplomer protein. Engineered: yes. Mutation: yes
Source: Severe acute respiratory syndrome coronavirus 2. 2019-ncov. Organism_taxid: 2697049. Gene: s, 2. Expressed in: homo sapiens. Expression_system_taxid: 9606
Authors: S.Gobeil,P.Acharya
Key ref: S.M.Gobeil et al. (2021). D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Rep, 34, 108630. PubMed id: 33417835
Date:
10-Oct-20     Release date:   04-Nov-20    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
P0DTC2  (SPIKE_SARS2) -  Spike glycoprotein from Severe acute respiratory syndrome coronavirus 2
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1273 a.a.
966 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 1 residue position (black cross)

 

 
Cell Rep 34:108630 (2021)
PubMed id: 33417835  
 
 
D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.
S.M.Gobeil, K.Janowska, S.McDowell, K.Mansouri, R.Parks, K.Manne, V.Stalls, M.F.Kopp, R.Henderson, R.J.Edwards, B.F.Haynes, P.Acharya.
 
  ABSTRACT  
 
The severe acute respiratory coronavirus 2 (SARS-CoV-2) spike (S) protein is the target of vaccine design efforts to end the coronavirus disease 2019 (COVID-19) pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic and are now the dominant form worldwide. Here, we explore S conformational changes and the effects of the D614G mutation on a soluble S ectodomain construct. Cryoelectron microscopy (cryo-EM) structures reveal altered receptor binding domain (RBD) disposition; antigenicity and proteolysis experiments reveal structural changes and enhanced furin cleavage efficiency of the G614 variant. Furthermore, furin cleavage alters the up/down ratio of the RBDs in the G614 S ectodomain, demonstrating an allosteric effect on RBD positioning triggered by changes in the SD2 region, which harbors residue 614 and the furin cleavage site. Our results elucidate SARS-CoV-2 S conformational landscape and allostery and have implications for vaccine design.
 

 

spacer

spacer